Congress Overrides HHS Guidance on Use of Provider Relief Funds

11 January 2021 Health Care Law Today Blog
Author(s): Anil Shankar

Congress’ recently-passed Federal Appropriations Act includes new provisions modifying the scope of the Provider Relief Fund payments overseen by the U.S. Department of Health and Human Services (HHS), granting providers new flexibility in how they may use the funds they received. The legislation also authorizes HHS to distribute an addition $3 billion dollars in Provider Relief Fund payments. The legislation was signed into law on December 27, 2020.

Payments from the Provider Relief Fund were distributed quickly in Spring 2020 and many providers accepted funds even as HHS continued to issue guidance defining what it considered permissible uses of the funds. Under the program’s terms and conditions, funds may only be used to reimburse health care related expenditures or lost revenue attributable to coronavirus. Under the new legislation, Congress required HHS to permit providers to calculate lost revenues using the guidance HHS had issued as of June 2020, which read as follows:

You may use any reasonable method of estimating the revenue during March and April 2020 compared to the same period had COVID-19 not appeared. For example, if you have a budget prepared without taking into account the impact of COVID-19, the estimated lost revenue could be the difference between your budgeted revenue and actual revenue. It would also be reasonable to compare the revenues to the same period last year.

While questions remain about how providers will report their lost revenues, the new law reverses HHS’ more recent statements on calculating lost revenues and restores a presumption of provider flexibility in accounting for lost revenues attributable to coronavirus. HHS guidance from October had required providers to utilize a year-over-year calculation of change in revenue.

The new law also ensures that recipients of Provider Relief Fund payments have flexibility to transfer funds they receive among their corporate parents and subsidiaries. Specifically, Congress required that any reimbursement from the Provider Relief Fund may be allocated (through transfers or otherwise) among subsidiary eligible health care providers, including reimbursement that was marked by HHS as “Targeted Distribution” payments. Previously, guidance from HHS had indicated that, while General Distribution payments could be transferred among subsidiaries, Targeted Distribution payments must remain with the entity that was eligible for the Targeted Distribution payment. 

Providers that have received Provider Relief Funds should continue to carefully track HHS’ Frequently Asked Questions and other guidance. When not contradicted by Congress, this guidance will define HHS’ expectations for the permissible use of the funds and help providers prepare for reporting and audits.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services